Tevogen Bio remains steadfast in its mission to pioneer accessible and affordable precision medicine while advocating for fair and transparent market participation.

Stifel analyst Ian Gillies raised the firm’s price target on Russel Metals (RUSMF) to C$60 from C$55.50 and keeps a Buy rating on the ...

The UK government appears to have no sense of urgency to update its Maritime Decarbonisation Strategy, with its environmental ...